Tirzepatide (Monjaro) 25 mg ZPHC

Tirzepatide (Monjaro) 25 mg ZPHC 

Tirzepatide is a new, improved version of semaglutide. The main active ingredient is “Monjaro”. This drug was developed specifically for the treatment of obesity and diabetes. Tirzepatide has advantages over other peptides, demonstrating promising results. The main feature of the drug is a significant and sustained decrease in blood glucose levels and weight loss.

Tirzepatide was approved for use in the United States in May 2022. The FDA considers it the first drug of its kind. During the studies, it was found that when taking tirzepatide, weight loss occurs more intensively than when taking the more common semaglutide (Ozempic).

Tirzepatide is available in 5 mg vials. In addition, our box contains bacteriostatic water for diluting the suspension. The drug is used in the form of subcutaneous injections. In the United States, tirzepatide is also known under such brands as monjaro and zepbound.

The peculiarity of tirzepatide is that it simultaneously affects 2 receptors: GIP and GLP-1. With these unique combinations, the drug makes it possible to exercise more effective and comprehensive control over metabolism. Tirzepatide works on the following 3 principles:

• Suppresses appetite, makes it possible to control calories

• Regulates insulin production, reducing glucose levels

• Burns fat, lowers bad cholesterol

Advantages of tirzepatide. 

Tirzepatide, as a GLP-1 receptor agonist, has the following effects:

• Control of blood glucose levels

• Improved gastrointestinal function

• Protection of the cardiovascular system

• Weight loss and appetite control

 

Tirzepatide, as a GIP receptor agonist, has the following effects:

• Improved glucose control

• Increased feeling of satiety

• Promotes fat burning

In addition, it is important to note the effectiveness and safety of tirzepatide. As a means of weight loss and diabetes control, it is recognized as a safer means than semaglutide. The drug causes fewer side effects, the effectiveness of its use is higher by about 30%.

Course of tirzepatide. 

Who is suitable for the use of tirzepatide? First, it will be most effective for overweight people, patients with diabetes, as well as all people who would like to improve their health.

A box of 5 bottles is designed for approximately 6 weeks of use. It is recommended to use tirzepatide once a week, keeping the interval between doses at least 72 hours. You should start with 2.5 mg of the drug per week, gradually increasing the dosage. The maximum dosage can reach 15 mg per week.

During the course of taking tirzepatide, you must follow some recommendations:

• Take water-based protein shakes to maintain muscle mass

• Visit the gym, since strength training has a beneficial effect on metabolism

• It is recommended to increase fluid intake, this will help improve overall well-being, as well as maintain optimal water balance

For proper storage of the drug, it is recommended to place the bottle with powder in the freezer.

Shelf life of the powder:

At room temperature – up to 1 month.

In the refrigerator – up to 6 months.

In the freezer – up to 2 years.

Side effects 

It is not recommended to use tirzepatide for pregnant women, people under 18, pregnant women, as well as patients suffering from liver failure and thyroid cancer. In addition, there are contraindications for use for patients with diabetes and diabetic ketoacidosis.

If side effects occur, the dosage should be reduced. If you feel well, then the dosage is correct, and you are moving correctly. It is necessary to constantly monitor your health and adjust the dosage.

 

Where to buy tirzepatide in the USA? 

You can buy tirzepatide in our online store. Tirzepatide is currently an absolute hit as a weight loss product. If you want to lose weight, remove excess fat and improve the quality of your health, then tirzepatide is exactly what you were looking for. The most effective and safe product on the market. If you have any questions, we will be happy to answer them. Contact in the header of our site.